Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Director / PDMR shareholdings

2 Jul 2024 09:57

RNS Number : 7874U
Kainos Group plc
02 July 2024
 

02 July 2024

Kainos Group plc

("Kainos" or the "Company") 

 

Director / PDMR shareholdings

 

The Company announces that on 1 July 2024, share awards (the "Awards") approved by the Board of Directors of the Company under the Kainos Group plc SAYE Plan (the "SAYE Awards"), in the form of options over Ordinary Shares granted in accordance with the terms of the scheme, were awarded to all staff including executive directors and executive managers of the Company. 

 

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them.

 (A19 Market Abuse Regulation)

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Russell Sloan

2.

Reason for the notification

a.

Position/status

CEO

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of £0.005 each

 

KNOS

b.

Nature of the transaction

SAYE Share Awards 2024

c.

Price(s) and volume(s)

 

PSP Award1

Exercise Price(s)

Volume(s)

£9.39

575

 

 

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

01-07-24

f.

Place of the transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Richard McCann

2.

Reason for the notification

a.

Position/status

CFO/COO

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of £0.005 each

 

KNOS

b.

Nature of the transaction

SAYE Share Awards 2024

c.

Price(s) and volume(s)

 

PSP Award1

Exercise Price(s)

Volume(s)

£9.39

575

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

01-07-24

f.

Place of the transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Kieran Barber

2.

Reason for the notification

a.

Position/status

Head of Services

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Options over Ordinary Shares of £0.005 each

 

KNOS

b.

Nature of the transaction

SAYE Share Awards 2024

c.

Price(s) and volume(s)

 

PSP Award1

Exercise Price(s)

Volume(s)

£9.39

575

 

 

 

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

01-07-24

f.

Place of the transaction

Outside a trading venue

 

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Russell Sloan, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Ben Griffiths / Nick Prowting

 

FTI Consulting LLP +44 20 3727 1000

Dwight Burden / Kwaku Aning / Usama Ali

 

About Kainos

Kainos Group plc is a UK-headquartered provider of sophisticated IT services to major public sector, commercial and healthcare customers. Our expertise spans three divisions: Digital Services, Workday Services, and Workday Products.

 

Digital Services: We develop and support custom digital service platforms that transform service delivery in public, commercial, and healthcare sectors. Our solutions ensure security, accessibility, cost-effectiveness, and improved user outcomes.

 

Workday Services: Specialising in deploying Workday, Inc.'s Finance, HR, and Planning products, we are a respected partner in Europe and North America. Experienced in complex deployments, we are trusted to launch, test, expand, and support Workday systems.

 

Workday Products: Our established product suite, incorporating Smart Test, Smart Audit, and Smart Shield, complements Workday by enhancing system security and compliance. Our Employee Document Management product, launched in October 2023, improves document generation and storage within Workday while supporting global compliance requirements. Over 450 global customers use one or more of our products.

 

Our people are central to our success. We have more than 2,900 people in 23 countries across Europe, Asia, and the Americas.

 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us at www.kainos.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGIGDRUUGDGSD
Date   Source Headline
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20204:27 pmRNSBoard Committee Membership
25th Aug 20204:46 pmRNSHolding(s) in Company
19th Aug 202010:10 amRNSNotice of AGM
5th Aug 20201:13 pmRNSDirector/PDMR Shareholding
31st Jul 202011:29 amRNSTotal Voting Rights
31st Jul 20208:39 amRNSAnnual Report 2020
27th Jul 20207:00 amRNSTrading Update and Special Dividend
3rd Jul 20201:56 pmRNSDirector/PDMR Shareholding
1st Jul 202012:20 pmRNSTotal Voting Rights
30th Jun 20205:10 pmRNSCorrection: Director/PDMR Shareholding
30th Jun 20201:59 pmRNSDirector/PDMR Shareholding
9th Jun 202011:39 amRNSDirector Declaration
9th Jun 20208:59 amRNSDirector/PDMR Shareholding
1st Jun 202011:51 amRNSTotal Voting Rights
28th May 20205:00 pmRNSHolding(s) in Company
26th May 20207:00 amRNSPreliminary results for year ended 31 March 2020
1st May 20209:19 amRNSTotal Voting Rights
23rd Apr 202012:07 pmRNSSecond Price Monitoring Extn
23rd Apr 202012:02 pmRNSPrice Monitoring Extension
16th Apr 20207:00 amRNSTrading Update
14th Apr 20204:37 pmRNSPrice Monitoring Extension
1st Apr 20201:09 pmRNSTotal Voting Rights
2nd Mar 20207:00 amRNSKainos acquires IntuitiveTEK LLC
31st Jan 202011:28 amRNSTotal Voting Rights
6th Jan 20209:41 amRNSTotal Voting Rights
19th Dec 20195:46 pmRNSHolding(s) in Company
9th Dec 20192:37 pmRNSCORRECTION: Director/PDMR Shareholding
6th Dec 20193:29 pmRNSHolding(s) in Company
6th Dec 20193:29 pmRNSDirector/PDMR Shareholding
5th Dec 201912:02 pmRNSPrice Monitoring Extension
3rd Dec 20193:42 pmRNSDirector/PDMR Shareholding
29th Nov 20194:00 pmRNSHolding(s) in Company
29th Nov 20193:54 pmRNSDirector/PDMR Shareholding
29th Nov 201911:00 amRNSTotal Voting Rights
28th Nov 201910:42 amRNSAppointment of Non-Executive Director
20th Nov 201912:07 pmRNSSecond Price Monitoring Extn
20th Nov 201912:02 pmRNSPrice Monitoring Extension
11th Nov 20197:01 amRNSKainos Acquires Formulate and Implexa
11th Nov 20197:00 amRNSInterim Results
1st Nov 201911:15 amRNSTotal Voting Rights
30th Sep 20193:14 pmRNSTotal Voting Rights
26th Sep 20191:15 pmRNSChairman Appointment & Committee Membership Change
26th Sep 201912:00 pmRNSResults of Annual General Meeting
5th Sep 20195:31 pmRNSHolding(s) in Company
4th Sep 20197:00 amRNSTrading Update
3rd Sep 20193:44 pmRNSHolding(s) in Company
2nd Sep 201910:50 amRNSTotal Voting Rights
21st Aug 20191:40 pmRNSNotice of Annual General Meeting 2019
19th Aug 201912:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.